Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens

Journal of Clinical Microbiology

Volumn 35, Issue 9, 1997, Pages 2262-2265

  Cope, Judith U ^a   Hildesheim, Allan ^a   Schiffman, Mark H ^a   Manos, M Michele ^b   Lörincz, Attila T ^c   Burk, Robert D ^d   Glass, Andrew G ^c   Greer, Catherine ^e   Buckland, Julie ^f   Helgesen, Kay ^f   Scott, David R ^c   Sherman, Mark E ^a,g   Kurman, Robert J ^g   Liaw, Kai Li ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Digene Corporation   (United States)

^c KAISER PERMANENTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030793675     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.9.2262-2265.1997     Document Type: Article

References (29)

1. Abramson, J. H. 1994. Making sense of data, p. 177. Oxford University Press, New York, N.Y.
2. Bauer, H. M., C. E. Greer, and M. M. Manos. 1992. Determination of genital HPV infection using consensus PCR, p. 131-152. In C. S. Herrington and J. O. D. McGee (ed.), Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, England.
3. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
4. Bosch, F. X., M. M. Manos, N. Munoz, M. E. Sherman, A. Jansen, J. Peto, M. H. Schiffman, V. Moreno, K. V. Shah, and the IBSCC Study Group. 1995. Prevalence of HPV DNA in cervical cancer in 22 countries. J. Natl. Cancer Inst. 87:796-802.
5. Bosch, F. X., N. Munoz, S. De Sanjose, I. Izarzugaza, M. Gili, P. Viladiu, M. J. Tormo, P. Moreo, N. Ascunce, L. C. Gonzalez, L. Tafur, J. M. Kaldor, E. Guerrero, N. Aristizabal, M. Santamaria, P. Alonso de Ruiz, and K. Shah. 1992. Risk factors for cervical cancer in Columbia and Spain. Int. J. Cancer. 52:750-758.
6. Cox, J. T., A. T. Lorincz, M. H. Schiffman, M. E. Sherman, R. J. Kurman, M. Hussein, and A. Cullen. 1995. Human papillomavirus testing by Hybrid Capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172:946-954.
7. Cuzick, J., A. Szarewski, G. Terry, L. Ho, A. Hanby, P. Maddox, M. Anderson, G. Kocjan, S. T. Steele, and J. Guillebaud. 1995. Human papillomavirus testing in primary cervical screening. Lancet 345:1533-1536.
8. Farthing, A., P. Masterson, W. P. Mason, and K. H. Vousden. 1994. Human papillomavirus detection by Hybrid Capture and its possible clinical use. J. Clin. Pathol. 47:649-652.
9. Hildesheim, A., M. H. Schiffman, P. Gravitt, A. G. Glass, C. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon. J. Infect. Dis. 169:235-240.
10. Hsing, A. W., R. D. Burk, K. Liaw, C. Chen, T. Zhang, M. H. Schiffman, C. E. Greer, S. You, C. Hsieh, T. W. Huang, T. Wu, T. J. O'Leary, J. D. Seidman, and M. M. Manos. 1996. Interlaboratory agreement in a PCR-based human papillomavirus DNA assay. Cancer Epidemiol. Biomarkers Prev. 5:483-484. (Letter.)
11. International Agency for Research on Cancer. 1992. The epidemiology of human papillomavirus and cervical cancer, vol. 64. Report 119. International Agency for Research on Cancer, Lyon, France.
12. Kelsey, J. L., W. D. Thompson, and A. S. Evans. 1986. Methods in observational epidemiology. Oxford University Press. New York, N.Y.
13. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
14. Kurman, R. J., D. E. Henson, A. L. Herbst, K. L. Noller, and M. H. Schiffman. 1994. Interim guidelines for management of abnormal cervical cytology. JAMA 271:1866-1869.
15. Kuypers, J. M., C. W. Critchlow, P. E. Gravitt, D. A. Vernon, J. B. Sayer, M. M. Manos, and N. B. Kiviat. 1993. Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J. Clin. Microbiol. 31:1003-1006.
16. Munoz, N., F. X. Bosch, S. deSanjose, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzalez, J. M. Kaldor, E. Guerrero, A. Lorincz, M. Santamaria, P. A. deRuiz, N. Aristizabal, and K. Shah. 1992. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Columbia and Spain. Int. J. Cancer 52:743-749.
17. Parkin, D. M., P. Pisani, and J. Ferlay. 1993. Estimates of the worldwide frequency of eighteen major cancers in 1985. Int. J. Cancer 54:594-606.
18. Ritter, D. B., A. S. Kadish, S. H. Vermund, S. L. Romney, D. Villari, and R. D. Burk. 1988. Detection of human papillomavirus DNA in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am. J. Obstet. Gynecol. 159:1517-1525.
19. Schiffman, M. H. 1992. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst. 84:394-398.
20. Schiffman, M. H. 1992. Validation of HPV hybridization assays: Correlation of FISH, dot blot, and PCR with Southern blot, p. 169-179. In N. Munoz, F. X. Bosch, K. V. Shah and A. Meheus (ed.), The epidemiology of human papillomavirus and cervical cancer. International Agency for Research on Cancer Scientific Publications, Lyon, France.
21. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
22. Schiffman, M. H., H. M. Bauer, A. T. Lorincz, M. M. Manos, J. C. Byrne, A. G. Glass, D. M. Cadell, and P. M. Howley. 1991. A comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol. 29:573-577.
23. Schiffman, M. H., N. B. Kiviat, R. D. Burk, K. V. Shah, R. W. Daniel, R. Lewis, J. Kuypers, M. M. Manos, D. R. Scott, M. E. Sherman, R. J. Kurman, M. H. Stoler, A. G. Glass, B. B. Rush, I. Mielzynska, and A. T. Lorincz. 1995. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by Hybrid Capture. J. Clin. Microbiol. 3:545-550.
24. Schiffman, M. H., and M. E. Sherman. 1994. HPV testing can be used to improve cervical cancer screening, p. 265-277. In S. Srivastava (ed.), Molecular markers of early detection of cancer. Futura Publishing Co., Armonk, N.Y.
25. Sherman, M. E., M. H. Schiffman, A. T. Lorincz, M. M. Manos, D. R. Scott, R. J. Kurman, N. B. Kiviat, M. Stoler, A. G. Glass, and B. B. Rush. 1994. Towards objective quality assurance in cervical cytopathology: correlation of cytolpathologic diagnoses with detection of high risk HPV types. Am. J. Clin. Pathol. 102:182-187.
26. Smits, H. L., L. J. M. Bollen, S. P. Tjong-A-Hung, J. Vonk, J. van der Velden, F. J. W. Ten Kate, J. A. Kaan, B. W. Mol, and J. ter Schegget. 1995. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J. Clin. Microbiol. 33:2631-2636.
27. Vermund, S. H., M. H. Schiffman, G. L. Goldberg, D. B. Ritter, A. Weltman, and R. D. Burk. 1989. Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells. Am. J. Obstet. Gynecol. 160:304-308.
28. Walboomers, J. M., A. M. De Roda Husman, A. J. C. van den Brule, P. J. F. Snijders, and C. J. L. Meijer. 1994. Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer, p. 41-71. In P. L. Stern and M. A. Stanley (ed.), Human papillomaviruses and cervical cancer biology and immunology. Oxford University Press, New York, N.Y.
29. Wideroff, L., M. H. Schiffman, B. Nonnenmacher, N. Hubbert, R. Kirnbauer, C. E. Greer, et al. 1995. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis. 172:1425-1430.